CTBI
Community Trust Bancorp, Inc.
CTBI's fundamentals are strong, but it looks expensive: trading at 12x earnings, above its usual 10x. Analysts expect earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
CTBI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CTBI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CTBI.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
CTBI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.8x | $53.41 | -24% |
| Fair | 10x | $61.56 | -12% |
| Forward | 11x | $70.09 | — |
| Expensive | 12x | $72.83 | +3.9% |
| Current | 12x | $70.09 | — |
Historical ranges are pointers, not guarantees.
CTBI's PE is in its expensive range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
CTBI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
CTBI has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CTBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.46 | +6.3% |
| Q3 2026 | $6.08 | +18% |
| Q2 2026 | $5.97 | +18% |
| Q1 2026 | $5.71 | +19% |
| Q4 2025 | $5.43 | +18% |
| Q3 2025 | $5.17 | +17% |
| Q2 2025 | $5.08 | +17% |
| Q1 2025 | $4.79 | +11% |
| Q4 2024 | $4.61 | +5.7% |
CTBI has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
CTBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $79.7M | +11% |
| Q2 2026 | $78.5M | +12% |
| Q1 2026 | $74.2M | +12% |
| Q4 2025 | $74.7M | +14% |
| Q3 2025 | $71.5M | +14% |
| Q2 2025 | $70.2M | +14% |
| Q1 2025 | $66.2M | +13% |
| Q4 2024 | $65.7M | +16% |
CTBI's revenue has grown year over year for 11 quarters in a row: $80M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | -0.5 points |
| Q2 2026 | 49% | +2.6 points |
| Q1 2026 | 48% | +4.7 points |
| Q4 2025 | 47% | +2.7 points |
| Q3 2025 | 43% | -0.6 points |
| Q2 2025 | 46% | +3.9 points |
| Q1 2025 | 43% | +2.3 points |
| Q4 2024 | 45% | +3.6 points |
CTBI has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
CTBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.4M | -11% |
| Q2 2026 | $43.1M | +217% |
| Q1 2026 | $37.9M | +9.9% |
| Q4 2025 | $13M | -33% |
| Q3 2025 | $36.4M | +2.8% |
| Q2 2025 | $13.6M | -26% |
| Q1 2025 | $34.5M | +44% |
| Q4 2024 | $19.4M | +3.7% |
CTBI has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
CTBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +15K shares |
| 1 year | +0.3% | +61K shares |
| 3 years | +1.2% | +210K shares |
| 5 years | +1.7% | +306K shares |
| Available history | +2.1% | +374K shares |
CTBI has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $1.1M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CTBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -3.6x | Net Cash |
| Q1 2026 | -2.6x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | -4.1x | Net Cash |
| Q2 2025 | -3.2x | Net Cash |
| Q1 2025 | -2.9x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
CTBI has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CTBI.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
CTBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.8 | Neutral |
| Stochastic | 18.2 | Oversold |
CTBI's weekly RSI is 46 (neutral) and its Stochastic is 18 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
CTBI PE vs Financial Services Sector
| Metric | CTBI | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 11% below |
| PE % | 75 | 63 | 12 pts above |
CTBI is trading at 12x earnings, a 11% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
CTBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.5 | 3.3% below |
| 20 week MA | $74.8 | 6.2% below |
| 50 week MA | $67.7 | 3.6% above |
| 100 week MA | $60.4 | 16% above |
| 200 week MA | $51.4 | 36% above |
CTBI has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
CTBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.5 | $37.1 | -20% |
| 2021 | $37.1 | $43.3 | +17% |
| 2022 | $43.3 | $45.7 | +5.6% |
| 2023 | $45.7 | $43.9 | -4% |
| 2024 | $43.9 | $53.6 | +22% |
| 2025 | $53.6 | $57.8 | +7.8% |
| 2026 YTD | $57.8 | $70.1 | +21% |
CTBI has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.